People  |  News  |

Blogger

Cell and gene thrapy (CGT) manufacturing boom roars along

Cell and gene thrapy (CGT) manufacturing boom roars along

With a swell of R&D activity flowing into the development of cell and gene therapies over the past decade, a manufacturing shortage gripped the industry. This caused industry participants to express grave fears that the manufacturing shortage would threaten industry growth and lengthen time-to-market for these new types of living therapies

read more
1200 450 Anemocyte
Bluebird bio’s first gene therapy wins approval in Europe

Bluebird bio’s first gene therapy wins approval in Europe

Bluebird Bio Inc.’s first gene therapy, a treatment for an inherited blood disorder, was cleared by European Union regulators, another milestone for the field following U.S. approval of Novartis AG’s $2.1 million treatment for a lethal childhood disease

read more
1200 450 Anemocyte
Meet the World’s First Biotech Manufacturing Organization, BMO

Meet the World’s First Biotech Manufacturing Organization, BMO

CRO, CMO, CDMO. These acronyms are well known in the biotech and pharma industry. But what is a BMO? If you haven’t heard of it, don’t worry. After all, there is only one BMO worldwide. We have set out to discover more about it, this biotech manufacturing organization

read more
1024 294 Anemocyte
  • 1
  • 2

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961